RAVINDRANATH KOLLI: Open Payments
NPI 1093709040 · MONESSEN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,401 in 154 payments from 10 companies in 2025. Trend: 2023 $16,579 · 2024 $17,744 · 2025 $10,401
Speaker / faculty: $7,750Food & beverage: $2,293Travel & lodging: $249Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $8,343 |
| Otsuka America Pharmaceutical, Inc. | 33 | $419 |
| Vanda Pharmaceuticals Inc. | 20 | $373 |
| Teva Pharmaceuticals USA, Inc. | 11 | $312 |
| Janssen Pharmaceuticals, Inc | 15 | $302 |
| Neurocrine BioSciences, Inc. | 22 | $283 |
| Alkermes, Inc. | 20 | $268 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Indivior Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: VRAYLAR, INGREZZA, INVEGA SUSTENNA, ARISTADA, FANAPT, ABILIFY ASIMTUFII, REXULTI, UZEDY.
Industry payments across PA — which companies pay providers there.
